§ Lord Clement-Jonesasked Her Majesty's Government:
Whether low-income patients at low to moderate risk of cardiovascular disease will have access to simvastatin on prescription, should its status be changed from a prescription-only to a pharmacy medicine. [HL2024]
§ Lord WarnerGeneral practitioners will continue to prescribe for patients on the basis of their assessment of individual clinical need, as they do now. The Committee on Safety of Medicines has recently been considering their advice on whether simvastatin 10mg should be switched from prescription-only to be available for sale by pharmacists.